Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Eur J Med Chem ; 199: 112425, 2020 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-32422522

RESUMO

Several steroids (abiraterone, prednisone, testosterone, cholesterol) and the BCL-2 inhibitor bexarotene were used as starting materials to synthesize iperazinyl-spacered rhodamine B conjugates. The conjugates were screened for their cytotoxicity in SRB assays against several human tumor cell lines and found to be active in a low µM to nM range. The conjugate derived from testosterone held an EC50 = 59 nM against MCF-7 tumor cells and acted mainly by necrosis. The prednisone conjugate, however, was less cytotoxic but acted mainly by apoptosis and held a moderate selectivity against MCF-7 tumor cells.


Assuntos
Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Mitocôndrias/efeitos dos fármacos , Androstenos/síntese química , Androstenos/química , Androstenos/farmacologia , Antineoplásicos/síntese química , Antineoplásicos/química , Bexaroteno/síntese química , Bexaroteno/química , Bexaroteno/farmacologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Colesterol/síntese química , Colesterol/química , Colesterol/farmacologia , Relação Dose-Resposta a Droga , Ensaios de Seleção de Medicamentos Antitumorais , Humanos , Estrutura Molecular , Prednisona/síntese química , Prednisona/química , Prednisona/farmacologia , Rodaminas/síntese química , Rodaminas/química , Rodaminas/farmacologia , Relação Estrutura-Atividade , Testosterona/síntese química , Testosterona/química , Testosterona/farmacologia
2.
An Real Acad Farm ; 85(3): 248-259, jul.-sept. 2019. graf, ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-184874

RESUMO

El objetivo de este trabajo fue estudiar la influencia de la divisibilidad en comprimidos de prednisona 30 mg. La división de comprimidos se utiliza a menudo en la práctica farmacéutica para ajustar las dosis administradas. La prednisona es un corticoesteroide (glucocorticoide) utilizado en el tratamiento de sustitución en la insuficiencia adrenal incluyendo entre otras la enfermedad de Addison. Como medicamento de referencia se utilizó Dacortin 30 mg, el cual se comparó con dos medicamentos genéricos. Se estudiaron diferentes características farmacotécnicas para evaluar la calidad de los comprimidos estudiados, tales como la disgregación y la resistencia a la rotura. Atendiendo al estudio de fraccionamiento de comprimidos, se determinó la diferencia sobre el peso teórico esperado (pérdida de masa media tras el fraccionamiento de cada marca comercial). La liberación del principio activo se estudió mediante el ensayo de velocidad de disolución en fracciones de comprimidos. Los resultados de las tres presentaciones comerciales fueron estudiados y analizados estadísticamente con un nivel de confianza de un 95 %


The objective of this work was to study the influence of the division in prednisone tablets 30 mg. The division of tablets is often used in pharmaceutical practice to adjust the administered doses. Prednisone is a corticosteroid (glucocorticoid) used in the substitution treatment in adrenal insufficiency including, among others, Addison's disease. As a reference drug, Dacortin 30 mg was used, and compared with two generic drugs. Different pharmacotechnic characteristics were studied to evaluate the quality of the tablets studied, such as disintegration, and the resistance to crushing. Based on the study of tablet fractionation, the difference over the expected theoretical weight was determined (loss of average mass after the fractionation of each trademark). The release of the active substance was carried out with dissolution rate study in fractions of tablets. The results of the three commercial formulations were studied and statistically analyzed with a confidence level of 95 %


Assuntos
Prednisona/química , Comprimidos/química , Medicamentos Fracionados , Medicamentos Genéricos/química , Prednisona/síntese química , Medicamentos Genéricos/síntese química , Comercialização de Medicamentos , Microscopia Eletrônica de Varredura/métodos , Fotomicrografia
3.
Methods Mol Biol ; 1645: 15-27, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28710618

RESUMO

Corticosteroids are products of high industrial and commercial importance. There are dozens of different synthesis published for all of them. Some are coming from academia and some from industry. Here, industrial processes for the synthesis of prednisone, prednisolone, hydrocortisone, dexamethasone, betamethasone, and methylprednisolone are described. The starting material is diosgenin and the desired molecules are reached due to a good combination of chemistry and biotechnology that was developed along the second part of the twentieth century.


Assuntos
Corticosteroides/biossíntese , Hidrocortisona/biossíntese , Engenharia Metabólica/métodos , Sapogeninas/síntese química , Corticosteroides/síntese química , Corticosteroides/química , Hidrocortisona/química , Prednisolona/síntese química , Prednisolona/química , Prednisona/síntese química , Prednisona/química , Sapogeninas/química
5.
In. Minas Gerais (Estado). Secretaria do Estado de Saude. Coordenadoria Estadual de Dermatologia Sanitaria de Minas Gerais. Como reconhecer e tratar reações hansenicas. Belo Horizonte, Ilep, 2005. p.36-53, tab.
Monografia em Português | LILACS, Sec. Est. Saúde SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1247056
7.
J Nucl Med ; 28(6): 998-1005, 1987 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-3495649

RESUMO

No-carrier-added fluorine-18-labeled fluoroprednisone ([18F]21-fluoroprednisone) was synthesized by tosylate displacement in 2%-8% radiochemical yield in 80 min end of cyclotron bombardment (EOB), and its metabolism and distribution were investigated. After intravenous administration to rats, [18F]21-fluoroprednisone was rapidly cleared from the blood and biotransformed into [18F]20-dihydro-21-fluoroprednisone. The suitability of [18F]21-fluorocorticoids for receptor imaging in humans with positron emitting tomography will depend on the synthesis of compounds with high binding affinity and low rate of carbonyl reduction at C-20.


Assuntos
Flúor , Prednisona/análogos & derivados , Radioisótopos , Tomografia Computadorizada de Emissão , Animais , Marcação por Isótopo/métodos , Prednisona/síntese química , Ratos , Receptores de Glucocorticoides/análise , Distribuição Tecidual
9.
J Med Chem ; 22(11): 1428-32, 1979 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-118258

RESUMO

Two of the new anticancer drugs recently synthesized in our laboratory from conjugation of ara-C2 and several corticosteroids linked through a phosphodiester bond include prednisolone- (I) and prednisone-p-ara-C (II). They were demonstrated to be enzymatically hydrolyzed to the corresponding steroid and ara-CMP and the latter was further shown to be hydrolyzed to ara-C by phosphodiesterase I, snake venom, 5'-nucleotidase, and acid phosphatase. However, the conjugates were shown to be resistant to hydrolysis by alkaline phosphatase. The activity of conjugates I and II against L1210 lymphoid leukemia in female mice (C3D2F1/J) was significantly greater than that of ara-C alone or in combination with the steroid. In fact, when the optimum dosage of 75 (mumol/kg)/day x 5 was used, the administration of ara-C alone was followed by an increased life span (ILS) of 45%. This result is similar to that previously reported. With the same equimolar doses of mixtures of ara-C and either prednisolone or prednisone, the ILS values were 40 and 44%, respectively. However, when the conjugates were used, the ILS values were 89 and 100% respectively. These findings seem promising and have provided the bases for continued study of these new compounds.


Assuntos
Antineoplásicos/síntese química , Citarabina/análogos & derivados , Prednisolona/análogos & derivados , Prednisona/análogos & derivados , Animais , Divisão Celular/efeitos dos fármacos , Citarabina/síntese química , Citarabina/farmacologia , Feminino , Haplorrinos , Hidrólise , Técnicas In Vitro , Leucemia L1210/tratamento farmacológico , Camundongos , Papio , Prednisolona/síntese química , Prednisolona/farmacologia , Prednisona/síntese química , Prednisona/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...